VanS T349I mutation in Clostridioides difficile infection: phenotypic association and clinical outcomes | Synapse
February 22, 2026
VanS T349I mutation in Clostridioides difficile infection: phenotypic association and clinical outcomes
Puntos clave
The study aims to evaluate clinical outcomes in Clostridioides difficile infection cases related to the VanS T349I mutation.
Compared clinical outcomes of CDI cases with and without VanS T349I mutation.
Both groups were treated with vancomycin.
Utilized phenotypic association for analysis.
Identified variances in clinical outcomes between mutation-positive and mutation-negative CDI strains.
Monitored treatment effectiveness of vancomycin in both groups.
Resumen
Aim: This study aimed to compare clinical outcomes of Clostridioides difficile infection (CDI) cases associated with strains with and without VanS T349I mutation that were treated with vancomycin.